This activity is intended for hematologists/oncologists, pulmonologists, and pathologists.
The goal of this activity is to increase clinicians' understanding of timmune modulators used in the management of patients with metastatic non-small cell lung cancer (NSCLC)
Have increased knowledge regarding the mmune modulators being studied to treat patients with metastatic NSCLC (mNSCLC), including how they may manipulate the immune system to improve recognition of cancer cells, tumors, and metastases
Have increased knowledge regarding the ongoing immunotherapy clinical trials in the management of patients with mNSCLC
Approximate Time to Complete: 15 minutes
Credit Available: January 13, 2021 - January 13, 2022
Developed through a partnership between SITC and Medscape.
Additional Resources for Clinicans from SITC:
Certificate in Cancer Immunotherapy